Ibuprofen Tablets Recalled Due to Failed Impurities and Degradation Specifications
Preferred Pharmaceuticals is recalling 266 bottles of generic ibuprofen tablets due to failed impurities and degradation specifications discovered during stability testing. The affected lots were distributed in California and Nevada.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall for pharmaceutical product quality failures (impurities and degradation specifications). The rubric applies Score 3 to risk-of-harm products where injury has not yet been reported, which matches this situation.
Plain-English summary
Preferred Pharmaceuticals, Inc. is recalling Ibuprofen Tablets, USP 400mg (generic for Motrin) in 30-tablet bottles due to failed impurities and degradation specifications. The recall involves 266 bottles with lot codes B0223H (expires 5/31/2026) and C3023H (expires 9/30/2026). The product was manufactured by Dr. Reddy's Laboratories in Shreveport, Louisiana, and distributed in California and Nevada.
The product failed impurities and degradation specifications during 18-month stability testing.
Consumers with this product should contact their pharmacist or healthcare provider for guidance.
The recalled product
- Product
- Ibuprofen Tablets, USP 400mg, Generic for Motrin, Pkg Size: 30 tablets per bottle, Mfg: Dr. Reddy's Laboratories, Louisiana, Shreveport, NDC 68788-9110-03.
- Manufacturer
- Preferred Pharmaceuticals, Inc.
- Category
- Drug — Ibuprofen / Tablet
- Hazard
- Affected units
- 266
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot: B0223H
- Exp: 5/31/2026
- C3023H
- Exp: 9/30/2026.
Distribution
Related recalls
Same manufacturer · Preferred Pharmaceuticals, Inc.
See all →- HighGeri-Care artificial tears lubricant eye drops recalled over sterility assurance
FDA (Drugs) · 2026-04-15
- ModerateOndansetron blister packs recalled because tablets are falling out
FDA (Drugs) · 2025-12-24
- ModerateClindamycin Hydrochloride Capsules Recalled for cGMP Deviations
FDA (Drugs) · 2025-05-07
- HighDuloxetine Delayed-Release Capsules Recalled for Nitrosamine Impurity
FDA (Drugs) · 2024-05-29
- ModerateTizanidine tablets recalled nationwide for failed stability specifications
FDA (Drugs) · 2023-07-12
Same hazard · impurities
See all →- LowDabigatran Etexilate Capsules Recalled Due to Impurity Specification Failure
FDA (Drugs) · 2026-08-05
- ModerateGlycopyrrolate Oral Solution Recalled Due to Failed Impurities and Degradation Specifications
FDA (Drugs) · 2026-07-29
- ModerateMethohexital Sodium for Injection Recalled for Failed Impurities and Degradation Specifications
FDA (Drugs) · 2026-07-15
- ModerateMethohexital Sodium 100 mg/10 mL Compounded Drug Recalled Nationwide
FDA (Drugs) · 2026-07-15
- LowFexofenadine Hydrochloride Tablets 180 mg Recalled for Impurities
FDA (Drugs) · 2026-07-08